vimarsana.com
Home
Live Updates
Recursion Provides Business Updates and Reports First Quarte
Recursion Provides Business Updates and Reports First Quarte
Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
Entered into agreements to acquire Cyclica and Valence to bolster digital chemistry and generative AI capabilities in order to further create new chemical composition of matter for novel biological... | May 8, 2023
Related Keywords
Utah ,
United States ,
Toronto ,
Ontario ,
Canada ,
Salt Lake City ,
Chris Gibson ,
Recursion Pharmaceuticals Inc ,
Development Expenses ,
Program Generation ,
Cerebral Cavernous Malformation ,
Target Gamma ,
Recursion Class ,
Cavernous Malformation ,
Adenomatous Polyposis ,
Proficient Ovarian Cancer ,
Industrialized Program Generation ,
Shareholder Meeting ,
Recursion Annual Shareholder Meeting ,
Proxy Statement ,
Administrative Expenses ,
San Francisco Bay ,
Consolidated Statements ,
Consolidated Balance Sheets ,
Recursion Pharmaceuticals ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Ntered ,
Into ,
Agreements ,
O ,
Cquire ,
Cyclica ,
End ,
Talence ,
Holster ,
Digital ,
Chemistry ,
Enerative ,
Hi ,
Capabilities ,
N ,
Order ,
Urther ,
Create ,
Few ,
Chemical ,
Composition ,
F ,
Matter ,
Or ,
Ovel Rxrx Us75629v1044 ,